Regional Medical Laboratory, INC

Regional Medical Laboratory, INC was paid $17.61M by Medicaid between Jan 2018 and Sep 2022, across 276 billing codes. Its largest line is U0004, 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r — 15% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in Oklahoma

Rank by total paid#3 of 46

Median peer was paid$248K

This provider vs. median71×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	204,596	$3.27M
2019	194,763	$2.83M
2020	199,511	$3.46M
2021	255,484	$4.39M
2022	225,125	$3.67M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	15%	35,336	32,801	$2.67M
80050	General health panel	6.0%	31,142	31,046	$1.05M
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	5.8%	32,341	31,190	$1.02M
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	5.8%	32,410	31,258	$1.01M
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	3.6%	12,359	11,311	$643K
88305	Level IV - Surgical pathology, gross and microscopic examination	3.4%	16,818	14,627	$606K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	2.7%	72,134	65,799	$473K
80061	Lipid panel	2.5%	37,866	37,586	$448K
80053	Comprehensive metabolic panel	2.2%	44,054	40,574	$396K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	2.2%	17,966	17,781	$394K
88175	Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer	2.2%	15,904	15,779	$386K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	2.0%	12,934	12,816	$344K

264 more codes

87086	Culture, bacterial; quantitative colony count, urine	1.9%	45,134	$330K
84443	Thyroid stimulating hormone (TSH)	1.7%	21,804	$308K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	1.6%	8,989	$280K
87481		1.6%	9,103	$275K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	1.5%	10,061	$262K
83036	Hemoglobin; glycosylated (A1C)	1.4%	28,887	$250K
86780		1.2%	18,240	$218K
87070		<1%	21,100	$167K
87077		<1%	22,664	$166K
86762		<1%	12,892	$162K
87799		<1%	3,920	$144K
87340		<1%	15,245	$143K
84702		<1%	10,781	$142K
84439		<1%	16,931	$137K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	4,073	$133K
86803		<1%	9,849	$125K
87186		<1%	14,789	$117K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	3,854	$117K
80074		<1%	2,698	$114K
86850		<1%	13,496	$110K
88312		<1%	1,878	$108K
84403		<1%	4,822	$104K
88342		<1%	1,758	$103K
87902		<1%	487	$101K
87081		<1%	16,220	$98K
82728		<1%	7,899	$96K
83880		<1%	2,897	$96K
87522	Neg quan hep c or qual rna	<1%	2,707	$83K
88141		<1%	3,817	$83K
84481		<1%	5,019	$77K
82677		<1%	3,463	$76K
82105		<1%	5,196	$74K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	924	$74K
86235		<1%	4,707	$72K
86481		<1%	846	$72K
83655		<1%	6,528	$70K
87529		<1%	2,645	$70K
83516		<1%	8,535	$70K
83970		<1%	1,851	$68K
88313		<1%	1,525	$64K
86038		<1%	5,752	$62K
82670		<1%	2,402	$61K
86665		<1%	3,467	$56K
80048	Basic metabolic panel (calcium, ionized)	<1%	7,945	$55K
83550		<1%	6,515	$51K
82950		<1%	11,786	$51K
83001		<1%	2,914	$49K
86336		<1%	3,420	$49K
84270		<1%	2,862	$48K
87660		<1%	2,606	$47K
87510		<1%	2,642	$47K
87480		<1%	2,641	$47K
86696		<1%	3,167	$47K
88341		<1%	607	$46K
86376		<1%	3,796	$45K
87899		<1%	3,463	$43K
83735		<1%	7,168	$43K
82784		<1%	5,197	$42K
86140		<1%	8,936	$42K
83540		<1%	7,093	$41K
84153		<1%	2,386	$40K
88304		<1%	1,998	$39K
82607		<1%	2,773	$39K
86901		<1%	12,885	$36K
86900		<1%	12,978	$36K
83002		<1%	2,104	$35K
84146		<1%	1,971	$35K
85055		<1%	1,108	$34K
84144		<1%	1,815	$34K
86800		<1%	2,392	$32K
86160		<1%	2,323	$31K
86695		<1%	3,117	$31K
87205		<1%	7,797	$30K
87634		<1%	502	$30K
82951		<1%	2,466	$29K
86706		<1%	2,880	$28K
86039		<1%	2,849	$28K
83525		<1%	2,588	$26K
88307		<1%	140	$25K
85652		<1%	10,081	$25K
80076		<1%	3,346	$24K
82043		<1%	4,898	$24K
84436		<1%	3,825	$24K
81001		<1%	8,211	$24K
85027		<1%	4,006	$23K
86704		<1%	2,350	$23K
86225		<1%	2,071	$22K
86769		<1%	563	$22K
84550		<1%	5,101	$21K
85610		<1%	5,609	$21K
86664		<1%	1,473	$20K
82746		<1%	1,505	$20K
86757		<1%	1,116	$20K
86431		<1%	4,477	$20K
83615		<1%	3,497	$19K
86003		<1%	4,895	$19K
86708		<1%	1,877	$19K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	1,367	$18K
88344		<1%	198	$18K
84100		<1%	4,222	$18K
86663		<1%	1,500	$18K
87075		<1%	2,055	$18K
86200		<1%	1,608	$18K
82627		<1%	1,007	$17K
82274		<1%	1,467	$17K
84480		<1%	1,279	$16K
82550		<1%	2,604	$15K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	314	$15K
80164		<1%	1,217	$15K
82785		<1%	1,064	$15K
87045		<1%	1,804	$14K
86709		<1%	1,407	$14K
83690		<1%	2,267	$14K
86677		<1%	1,022	$14K
87046		<1%	1,813	$14K
83520		<1%	1,143	$13K
82570		<1%	2,829	$13K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	301	$13K
87147		<1%	2,551	$12K
82247		<1%	2,593	$12K
82120		<1%	2,358	$12K
82248		<1%	2,556	$12K
86480		<1%	179	$11K
87210		<1%	2,080	$10K
81003		<1%	5,832	$10K
83883		<1%	761	$10K
86666		<1%	577	$10K
84156		<1%	3,029	$10K
87512		<1%	253	$10K
86258		<1%	975	$10K
87209		<1%	557	$9K
86787		<1%	791	$9K
80177		<1%	836	$9K
83721		<1%	988	$9K
82952		<1%	2,243	$8K
82977		<1%	1,246	$8K
82150		<1%	1,379	$8K
86618		<1%	552	$8K
87015		<1%	1,476	$8K
83498		<1%	302	$8K
80069		<1%	995	$8K
88142		<1%	430	$8K
87102		<1%	1,048	$8K
85730		<1%	1,573	$8K
82533		<1%	526	$8K
87328		<1%	612	$7K
86362		<1%	800	$7K
85007		<1%	2,077	$7K
85018		<1%	3,132	$7K
84681		<1%	461	$7K
87338		<1%	705	$7K
87329		<1%	611	$7K
82024		<1%	216	$7K
86060		<1%	979	$6K
86147		<1%	253	$6K
87449		<1%	556	$6K
85045		<1%	1,660	$6K
83993		<1%	569	$6K
86694		<1%	463	$6K
83986		<1%	1,856	$6K
86317		<1%	80	$6K
85014		<1%	2,639	$6K
86668		<1%	498	$6K
87279		<1%	378	$5K
84703		<1%	777	$5K
88185		<1%	27	$5K
80197		<1%	571	$5K
80178		<1%	794	$5K
81025		<1%	662	$5K
87324		<1%	441	$5K
87177		<1%	532	$4K
84479		<1%	701	$4K
84134		<1%	325	$4K
86162		<1%	156	$3K
84165		<1%	357	$3K
84305		<1%	222	$3K
87185		<1%	689	$3K
80175		<1%	248	$3K
87808		<1%	205	$3K
86644		<1%	197	$3K
83090		<1%	158	$3K
86146		<1%	121	$3K
85379		<1%	253	$2K
88112		<1%	77	$2K
86308		<1%	425	$2K
86645		<1%	139	$2K
83020		<1%	225	$2K
87536		<1%	29	$2K
86256		<1%	185	$2K
84484		<1%	174	$2K
86738		<1%	90	$2K
82397		<1%	150	$2K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	160	$2K
82947		<1%	469	$2K
83521		<1%	114	$2K
87517		<1%	62	$2K
86255		<1%	169	$2K
84590		<1%	148	$2K
84446		<1%	118	$1K
84478		<1%	259	$1K
82103		<1%	176	$1K
86592		<1%	395	$1K
87101		<1%	153	$1K
87493		<1%	37	$1K
84425		<1%	63	$1K
86812		<1%	123	$1K
82140		<1%	83	$1K
85613		<1%	194	$1K
82672		<1%	52	$1K
84482		<1%	74	$1K
82542		<1%	44	$976.06
85705		<1%	167	$950.22
84432		<1%	110	$949.46
84402		<1%	39	$863.57
87184		<1%	129	$826.67
82652		<1%	29	$824.53
83013		<1%	13	$778.96
86870		<1%	38	$771.84
82390		<1%	97	$741.59
86036		<1%	68	$667.72
84155		<1%	235	$644.17
82378		<1%	39	$640.68
84460		<1%	123	$628.55
84630		<1%	61	$608.19
86747		<1%	37	$594.77
86021		<1%	74	$570.33
86617		<1%	41	$464.70
86304		<1%	31	$453.44
83789		<1%	27	$450.98
88184		<1%	13	$446.74
84154		<1%	27	$441.72
84450		<1%	85	$435.43
82157		<1%	15	$413.40
87040		<1%	45	$413.10
86880		<1%	78	$407.12
86141		<1%	25	$330.05
80156		<1%	27	$326.49
88300		<1%	24	$322.75
84255		<1%	13	$298.81
82681		<1%	12	$298.20
89055		<1%	79	$297.33
83018		<1%	15	$296.68
82530		<1%	17	$287.01
36415	Collection of venous blood by venipuncture	<1%	5,501	$279.87
82553		<1%	27	$267.02
87254		<1%	14	$258.18
86361		<1%	13	$246.76
87807		<1%	20	$246.45
87076		<1%	33	$237.27
84466		<1%	19	$215.65
82668		<1%	12	$200.52
85660		<1%	42	$189.70
82239		<1%	14	$188.43
82985		<1%	14	$179.90
82943		<1%	13	$166.07
85246		<1%	29	$130.22
82180		<1%	12	$120.36
85240		<1%	25	$105.04
81015		<1%	29	$73.17
82565		<1%	14	$64.34
84520		<1%	15	$50.86
84132		<1%	12	$50.76
83930		<1%	283	$12.92
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	0%	113	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialDOLAN, CHARLES (PRESIDENT)